Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pelttari

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Contact Dermatitis|April 6, 2000
Occupational allergic contact dermatitis from Compositae in agricultural workL Kanerva, K Alanko, M Pelttari, et al.
Allergy|December 5, 2002
Occupational contact urticaria from diglycidyl ether of bisphenol A epoxy resinL Kanerva, M Pelttari, R Jolanki, et al.
BMC Cancer|November 27, 2012
Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patientsLiisa M Pelttari, Riikka Nurminen, Alexandra Gylfe, et al.
Springerplus|April 29, 2015
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer familiesLiisa M Pelttari, Johanna I Kiiski, Salla Ranta, et al.
Familial Cancer|September 10, 2015
Screening of HELQ in breast and ovarian cancer familiesLiisa M Pelttari, Laura Kinnunen, Johanna I Kiiski, et al.
Allergy|March 4, 2000
Chlorendic anhydride allergyH Keskinen, P Pfäffli, M Pelttari, et al.
Breast Cancer Research : BCR|December 17, 2011
Variants on the promoter region of PTEN affect breast cancer progression and patient survivalTuomas Heikkinen, Dario Greco, Liisa M Pelttari, et al.
Maedica|July 5, 2021
New VOUS in <i>CASK</i> Gene Correlating with the MICPCH PhenotypeElena Silvia Shelby, Onda Tabita Lupu, Mihaela Axente, et al.
Human Molecular Genetics|May 28, 2011
RAD51C is a susceptibility gene for ovarian cancerLiisa M Pelttari, Tuomas Heikkinen, Deborah Thompson, et al.
BMC Cancer|September 7, 2017
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient populationSanna Hallamies, Liisa M Pelttari, Paula Poikonen-Saksela, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Contact Dermatitis|April 6, 2000
Occupational allergic contact dermatitis from Compositae in agricultural workL Kanerva, K Alanko, M Pelttari, et al.
Allergy|December 5, 2002
Occupational contact urticaria from diglycidyl ether of bisphenol A epoxy resinL Kanerva, M Pelttari, R Jolanki, et al.
BMC Cancer|November 27, 2012
Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patientsLiisa M Pelttari, Riikka Nurminen, Alexandra Gylfe, et al.
Springerplus|April 29, 2015
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer familiesLiisa M Pelttari, Johanna I Kiiski, Salla Ranta, et al.
Familial Cancer|September 10, 2015
Screening of HELQ in breast and ovarian cancer familiesLiisa M Pelttari, Laura Kinnunen, Johanna I Kiiski, et al.
Allergy|March 4, 2000
Chlorendic anhydride allergyH Keskinen, P Pfäffli, M Pelttari, et al.
Breast Cancer Research : BCR|December 17, 2011
Variants on the promoter region of PTEN affect breast cancer progression and patient survivalTuomas Heikkinen, Dario Greco, Liisa M Pelttari, et al.
Maedica|July 5, 2021
New VOUS in <i>CASK</i> Gene Correlating with the MICPCH PhenotypeElena Silvia Shelby, Onda Tabita Lupu, Mihaela Axente, et al.
Human Molecular Genetics|May 28, 2011
RAD51C is a susceptibility gene for ovarian cancerLiisa M Pelttari, Tuomas Heikkinen, Deborah Thompson, et al.
BMC Cancer|September 7, 2017
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient populationSanna Hallamies, Liisa M Pelttari, Paula Poikonen-Saksela, et al.
Pageof 5